indication

Treatment Resistant Disorders

Competitive landscape

as of 2026-07-01
Competitive set
2
1 approved · 1 pipeline

Projection timeline

actual past → guided future · protection walls overlaid
4 events
2022
2024
2026
2028
2030
2032
2034
2036
2038
today
focal launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff

Competitive set

resolved drugs with trials in this indication
drugWithdrawn
Clozapine
US-approved 1989 · Clozaril
—1 trial
OwnerShanghai Mental Health Center
Protection2028
drugWithdrawn
Amisulpride
Investigational
—1 trial
OwnerShanghai Mental Health Center
Protection2038

Market size

prevalence as a range, not a number